Colorectal Cancer, Genetics of Clinical Trial
Transcriptiomic Analysis of Inflammatory Bowel Disease-associated Colorectal Cancer. A French Retrospective Study of 26 Cases Identified at the Nancy University Hospital
Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very different clinically from de novo CRCs, are currently unknown. The aim of our work is to identify specific molecular signatures of CRC occurring in the setting of IBD.
|Study type||Observational [Patient Registry]|
|Source||Central Hospital, Nancy, France|
|Start date||January 1, 2010|
|Completion date||January 1, 2021|